The Effect Of 6-Weeks Daily Blueberry Powder Ingestion On Plasma Antioxidant Capacity And Oxidative Damage In Relationship To Sarcopenia by Behrens Jr., Christian E. & NC DOCKS at Appalachian State University
	
	
	
	
	
	
	
	
	
THE	EFFECT	OF	6-WEEKS	DAILY	BLUEBERRY	POWDER	INGESTION	ON	PLASMA	
ANTIOXIDANT	CAPACITY	AND	OXIDATIVE	DAMAGE	IN	RELATIONSHIP	TO	
SARCOPENIA	
	
	
	
	
	
	
	
A	Thesis		
by	
CHRISTIAN	E.	BEHRENS	JR.	
	
	
	
	
	
	
Submitted	to	the	Graduate	School	
	at	Appalachian	State	University	
in	partial	fulfillment	of	the	requirements	for	the	degree	of	
MASTER	OF	SCIENCE	
	
	
	
	
	
	
	
	
	
AUGUST,	2016	
NUTRITION	AND	HEALTHCARE	MANAGEMENT	
	
	
	
	
	 	
	
	
	
	
	
	
THE	EFFECT	OF	6-WEEKS	DAILY	BLUEBERRY	POWDER	INGESTION	ON	PLASMA	
ANTIOXIDANT	CAPACITY	AND	OXIDATIVE	DAMAGE	IN	RELATIONSHIP	TO	
SARCOPENIA	
	
	
	
A	Thesis		
by	
CHRISTIAN	E.	BEHRENS	JR.	
AUGUST,	2016	
	
	
	
	
	
APPROVED	BY:		
	 	
	
	 	 	 	 	 	 	 	
Lisa	McAnulty,	RD,	PhD	
Chairperson,	Thesis	Committee	
	
	
	 	 	 	 	 	 	 	
Steven	McAnulty,	PhD	
Member,	Thesis	Committee	
	
	
	 	 	 	 	 	 	 	
Kyle	Thompson,	RD,	LDN	
Member,	Thesis	Committee	
	
	
	 	 	 	 	 	 	 	
Sarah	Jordan,	RD,	PhD	
Chairperson,	Department	of	Nutrition	and	Healthcare	Management		
	
	
	 	 	 	 	 	 	 	
Max	C.	Poole,	Ph.D.	
Dean,	Cratis	D.	Williams	School	of	Graduate	Studies	
	 	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Copyright	by	Christian	E.	Behrens	Jr.	2016	
All	Rights	Reserved	
	
	
	
iv	
	
Abstract	
	
THE	EFFECT	OF	6-WEEKS	DAILY	BLUEBERRY	POWDER	INGESTION	ON	PLASMA	
ANTIOXIDANT	CAPACITY	AND	OXIDATIVE	DAMAGE	IN	RELATIONSHIP	TO	
SARCOPENIA	
	
Christian	E.	Behrens	Jr.		
B.S.,	Appalachian	State	University	
M.S.,	Appalachian	State	University	
	
	
Chairperson:		Lisa	McAnulty,	RD,	PhD	
	
	
	 Sarcopenia	is	a	loss	of	muscle	associated	with	reduced	physical	capacity.		
Muscle	undergoes	inflammation	followed	by	rebuilding	after	weight	lifting.		This	
is	known	as	the	muscle	regenerative	stimulus	(MRS).		Blueberries	contain	anti-
inflammatories	and	could	be	crucial	in	enhancing	anti-inflammatory	responses	
associated	with	weight	training.		Combining	these	two	regimens	may	combat	
sarcopenia.		To	examine	this	combined	mechanism,	21	participants	over	age	60	
were	randomized	into	blueberry	(BB)	(n=10)	or	placebo	(PLA)	(n=11)	groups	
and	given	6-wks	of	blueberry	powder	supplementation	(38g/d)	or	a	placebo.		
Individuals	reported	to	the	laboratory	three	times.		Visit	1	consisted	of	a	medical	
screen,	diet	instruction,	anthropometric	measurements,	and	blood	draw.		Visit	2,	
6-wks	afterwards,	included	anthropometric	measurements,	diet	history,	and	
blood	samples.		Visit	3,	24-hrs	following	the	MRS,	involved	obtaining	final	blood	
samples.		Blood	was	analyzed	for	ferric	reducing	ability	of	plasma	(FRAP),	a	
measure	of	antioxidant	capacity,	and	F2-isoprostanes,	a	measure	of	lipid	
peroxidation.		No	differences	were	observed	between	groups	for	age	or	
anthropometric	measures.		FRAP	and	F2-isoprostanes	were	not	significantly	
	
	
	
	
v	
different	between	BB	or	PLA.		Pre-BB	vitamin	C	and	selenium	intakes	were	
higher	vs.	PLA	but	did	not	affect	FRAP.		Blueberry	powder,	as	given	for	6-wks,	
does	not	alter	FRAP	or	F2-isoprostanes	in	an	older	population.		Blueberry	
metabolites	capable	of	exerting	antioxidant	effects	may	be	short-lived.		Future	
research	should	focus	on	acute	supplementation	effects.	
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1	
	
INTRODUCTION	
	
	
	
Aging	is	a	complex,	multifaceted	process	associated	with	progressive	
physiological,	molecular,	and	genetic	changes	that	are	responsible	for	an	increased	risk	
for	morbidity	and	mortality.1		These	age-related	changes,	paralleled	with	an	increased	
overall	life	expectancy,	highlight	the	paramount	need	to	identify	and	implement	dietary	
and	lifestyle	interventions	to	preserve	overall	health	and	functional	independence	with	
increasing	age.2		Several	hypotheses	in	the	literature	attempt	to	elucidate	these	
deleterious	age-related	effects.3-5		One	such	hypothesis	focuses	on	the	age-related	loss	
of	skeletal	muscle	mass,	termed	sarcopenia.		Sarcopenia	is	a	syndrome	best	
characterized	by	a	progressive	loss	of	skeletal	muscle.		Skeletal	muscle,	or	lean	body	
mass,	is	accrued	and	maintained	by	the	consumption	and	storage	of	protein	from	the	
diet.		Skeletal	muscle	is	also	the	primary	storage	site	for	protein;	up	to	60%	of	total	
body	protein	is	contained	within	the	body’s	lean	mass.		Since	protein	is	the	building	
block	of	lean	mass,	a	decrease	in	lean	mass	brought	on	by	sarcopenia	leads	to	a	
decrease	in	protein	storage,	and	a	decrease	in	protein	storage	leads	to	a	decreased	
ability	to	build	and	maintain	muscle	which	exacerbates	the	condition	throughout	older	
adulthood.		The	condition	occurs	gradually	with	increasing	age	and	is	strongly	tied	to	a	
decrease	in	physical	activity,	also	associated	with	aging.			After	the	age	of	50,	there	is	a	
progressive	decrease	in	muscle	mass	at	a	rate	of	1-2%	per	year.		Similarly,	muscle	
strength	also	decreases	by	roughly	3%	yearly	after	the	age	of	60.6		
	
	
	2 
	
One	of	the	potential	causes	of	muscle	aging	is	a	reduced	ability	for	the	muscle	to	
regenerate	due	to	an	exaggerated	response	to	inflammatory	mediators,	termed	“muscle	
inflammation	susceptibility”.7		Old	muscle	is	less	efficient	at	healing	itself,	compared	to	
young	muscle.		Conboy	and	colleagues8	showed	this	by	observing	muscle	regeneration	
between	young	and	old	mice	exposed	to	similar	damage.		Further,	when	exposing	old	
mice	to	factors	present	in	the	serum	of	young	mice,	there	was	an	increase	in	
regenerative	capacity	after	damage.		The	atrophy	of	aging	muscle	may	also	be	caused	in	
part	by	episodes	of	incomplete	muscle	repair	throughout	adulthood.		Whether	this	is	a	
normal	part	of	aging	is	not	known	for	sure;	however,	there	is	no	debate	that	the	
muscle’s	regenerative	capacity	is	compromised	with	age	and	following	overt	muscle	
damage.8-10			
Additionally,	the	examination	of	cytokines	in	circulation	indicates	that	the	
muscles	of	the	elderly	have	increased	and	prolonged	pro-inflammatory	signaling	that	
leads	to	interference	with	myogenesis	and	an	overall	decrease	in	muscle	mass.		The	
increase	in	inflammatory	mediators	may	also	lead	to	an	increased	accumulation	of	free	
radicals.		Free	radicals	are	a	reactive	chemical	species	with	an	odd	number	of	electrons	
that	seek	to	pair	with	another	free	electron.11		Harman	and	colleagues12	first	postulated	
that	free	radicals	may	be	in	part	responsible	for	the	negative	effects	of	aging.		He	
proposed	that	the	aging	process	and	its	degenerative	consequences	are	directly	related	
to	free	radical-induced	damage	to	cells	and	the	body’s	inability	to	counterbalance	these	
Increase	in	age Decrease	in	muscle	mass
Decrease	in	
physical	activity
Decrease	in	
overall	nutrient	
consumption
Further	
decrease	in	
muscle	mass
	
	
	3 
damages	with	endogenous	antioxidant	defenses.	Harmon	revised	his	theory	in	1972	by	
identifying	the	mitochondria	as	the	culprit	behind	the	physiological	process	of	aging.		
Higher	consumption	of	oxygen	results	in	higher	levels	of	oxidative	damage.		Therefore,	
it	could	be	inferred	that	mitochondria	(consuming	the	most	intracellular	oxygen)	have	
greater	exposure	to	oxidative	damage	leading	to	a	shorter	lifespan.13		With	this	revision	
in	theory	came	several	other	studies	affirming	the	mitochondria	as	a	major	component	
of	cellular	aging.		As	such,	the	once	termed	“Free	Radical	Theory	of	Aging”	has	since	
been	renamed	the	“The	Mitochondria	Free	Radical	Theory	of	Aging”.14,15			
Reactive	oxygen	species	(ROS)	are	one	class	of	free	radicals	of	particular	
concern.		ROS	are	derived	naturally	from	oxidative	metabolism	and	have	a	greater	
reactivity	than	O2.		The	cells	of	aerobic	organisms	constantly	generate	ROS	by	the	
addition	of	a	single	electron	to	O2	molecules.		This	process	subsequently	brings	about	
damage	to	biological	macromolecules,	particularly	lipids,	proteins,	and	nucleic	acids.		
This	interface	between	normal	cellular	structures	and	ROS	can	lead	to	irreparable	
damage	to	the	cell	and	subsequent	cell	death.16,17		The	identification	of	free	radicals	as	
promoters	of	the	aging	process	may	imply	that	inhibition	might	limit	the	detrimental	
modifications	exerted	on	the	body.		Ergo,	if	molecules	with	antioxidant	capacities	can	
counteract	the	oxidative	damage,	these	compounds	may	also	play	a	key	role	in	
preventing	the	onset	of	age-related	health	conditions.18		
Antioxidants	are	substances	able	to	reduce	the	rate	at	which	oxidation	
occurs.19,20		The	main	function	of	antioxidants	is	to	maintain	a	state	of	balance	by	
preventing	the	transformation	of	ROS	and	instead	converting	them	to	more	stable	
molecules	(H2O	and	molecular	O2).		One	of	the	major	sources	of	antioxidants	is	the	
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diet.21		Increased	antioxidant	concentrations	are	inversely	associated	with	isoprostanes,	
a	marker	of	lipid	peroxidation	in	vivo.22		The	type	of	antioxidant	can	have	a	bearing	on	
effect	as	well	as	what	molecules	are	affected.		Hydrophobicity	is	one	such	characteristic	
that	can	dictate	both	the	function	and	location	of	an	antioxidant’s	action.		For	instance,	
fat	soluble	antioxidants	such	as	vitamin	E	are	more	effective	inhibiting	the	peroxidation	
of	lipoproteins.		Whereas,	antioxidants	that	are	water	soluble	in	nature	are	particularly	
efficient	in	the	aqueous	phase.		Also,	interesting	to	note,	antioxidants	typically	do	not	
act	independently.		More	often	than	not,	the	action	is	in	synergy	with	similar	
compounds	ingested	from	the	diet	or	compounds	produced	endogenously.23,24	
Assuming	an	important	role	for	free	radicals	and	inflammatory	processes	in	
muscle	degeneration,	an	appropriate	avenue	to	test	the	previously	mentioned	theory	of	
muscle	inflammation	susceptibility	would	be	to	prevent	the	local	muscle	inflammation.		
Certain	foods	with	high	concentrations	of	antioxidants	and	anti-inflammatory	
compounds	(anthocyanins)	are	ideal	candidates	to	test	this	theory	and	have	already	
been	shown	to	be	beneficial	in	reducing	circulating	inflammatory	markers	and	
improving	muscle	recovery	following	damage.25,26	Bowtell	and	colleagues27	examined	
the	effect	of	cherry	juice	on	the	inflammatory	profile	of	10	well-trained	male	
participants	(age	=	27.8	±	1.6	yr).		Participants	completed	two	main	trials	separated	by	
a	two-week	washout	period	and	were	given	30	mL	twice	per	day	of	either	
Montmorency	cherry	juice	concentrate	or	placebo.		Participants	were	exposed	to	an	
intensive	unilateral	leg	exercise	by	measuring	creatine	kinase,	high	sensitivity	CRP,	
total	nitrotyrosine,	protein	carbonyls	(PC),	total	antioxidant	capacity	and	maximum	
voluntary	contraction	and	found	that	consumption	improved	recovery	after	intensive	
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exercise.		Participants	in	the	experimental	group	exhibited	enhanced	recovery	of	knee	
extensor	maximum	isometric	strength	accompanied	by	a	reduction	in	serum	PC	
indicative	of	reduced	oxidative	damage.	These	results	align	with	those	of	Connolly	et	
al.28	who	utilized	a	randomized,	placebo-	controlled,	crossover	design	to	examine	the	
effect	of	twice	daily	ingestion	of	12	fluid	ounces	(fl	oz)	tart	cherry	juice	blend	for	eight	
days,	on	the	symptoms	of	muscle	damage	in	14	male	college	students.		Eccentric	elbow	
flexion	contractions	were	performed	to	obtain	measures	for	isometric	elbow	flexion	
strength,	pain,	muscle	tenderness,	and	relaxed	elbow	angle.			
Results	of	the	study	indicated	strength	loss	and	pain	to	be	significantly	less	in	the	
cherry	juice	trial	versus	the	placebo	with	no	significant	effect	on	relaxed	elbow	angle	
and	muscle	tenderness.	Similar	benefits	of	cherry	juice	were	exhibited	by	Howatson	et	
al.29	who	examined	the	efficacy	of	tart	cherry	juice	in	ameliorating	recovery,	reducing	
muscle	damage,	inflammation	and	oxidative	stress	in	20	recreational	marathon	
runners.			
Participants	in	the	study	were	assigned	to	either	an	experimental	or	placebo	
group.		Participants	consumed	two,	8	fl	oz	servings	of	a	tart	cherry	blend	or	placebo	five	
days	prior	to	and	for	48	hours	following	a	marathon	run.		Markers	of	muscle	damage	
(CK,	LDH,	muscle	soreness	and	isometric	strength),	inflammation	(IL-6,	CRP	and	uric	
acid),	total	antioxidant	status	(TAS)	and	oxidative	stress	(thiobarbituric	acid	reactive	
species)	were	examined	before	and	after	the	marathon	race.			
Results	from	the	study	demonstrated	a	significantly	more	rapid	recovery	time	in	
the	cherry	group.		None	of	the	other	damage	indices	were	significantly	different.		These	
outcomes	may	have	occurred	due	to	the	mitigation	of	oxidative	damage	by	the	high	
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phenolic	capacity	of	the	cherry	juice.		However,	these	studies	did	not	directly	determine	
inflammation	status,	localized	muscle	response	or	the	potential	benefit	to	aging	muscle.		
Blueberries	have	a	much	higher	anthocyanin	concentration	making	them	desirable	to	
test	for	effectiveness	in	restoring	the	inflammatory	profile	of	aged	muscle	and	further	
improving	the	aged	muscle	regenerative	response;	thereby,	slowing	the	rate	of	overall	
muscle	loss	associated	with	age.30-33	
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METHODOLOGY	
	
	
Approval	for	this	study	was	obtained	from	the	Institutional	Review	Board	of	Appalachian	
State	University.	IRB#	15-0035	
	
Inclusion	and	Exclusion	Criteria	
Participants	recruited	for	this	study	consisted	of	men	and	women	aged	60	years	
or	older.		Participants	were	cleared	for	physical	activity	through	completion	of	a	health	
history	questionnaire.		The	results	of	the	health	history	questionnaire	allowed	for	
exclusion	of	individuals	with	any	disorder,	musculoskeletal	or	other,	that	would	
preclude	them	from	completing	exercise	tests.		Individuals	with	any	chronic	end-stage	
disease	expected	to	limit	life	expectancy	to	less	than	one	year,	induce	anorexia,	or	
restrict	physical	activity	were	excluded.		These	conditions	include,	but	are	not	limited	
to,	heart	failure,	end-state	COPD,	malignancy,	renal	failure,	AIDS,	or	any	disease	leading	
to	a	chronic	inflammatory	state.		Individuals	with	uncontrolled	hypertension,	unstable	
or	exercise-induced	angina	pectoris	or	myocardial	ischemia,	uncontrolled	diabetes	
mellitus	or	other	medical	conditions	that	would	interfere	with	testing	or	increase	one’s	
risk	of	complications	during	exercise	and/or	mechanical	load	injury	were	excluded	
from	participation.		Individuals	with	seated	resting	systolic	blood	pressure	>179	mmHg	
or	a	diastolic	blood	pressure	>110	mmHg	were	further	excluded.		Individuals	with	a	
lidocaine	allergy	were	excluded,	as	lidocaine	was	used	as	an	anesthetic	agent	during	the	
muscle	biopsy.		Individuals	on	prescription	anti-coagulants	or	persons	taking	a	daily	
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aspirin	not	willing	to	stop	were	also	excluded.		Additionally,	those	individuals	with	a	
BMI>30	as	well	as	those	receiving	androgen,	estrogen	or	anabolic	therapy	were	
excluded.		Participants	did	not	have	a	history	of	regular	resistance	training	during	the	6	
months	prior	to	recruitment	and	were	not	advised	not	to	take	prescription	anti-
inflammatory	medications.	
	
Recruitment	
Several	efforts	were	made	in	the	recruitment	of	participants.		A	request	was	sent	
to	the	faculty	and	staff	of	Appalachian	State	University	through	the	university	listserv.		
Additionally,	flyers	(Appendix	A)	were	placed	at	various	community	agencies	in	the	
town	of	Boone	to	advertise	the	study.	
	
Informed	Consent		
Informed	consent	(Appendix	B)	was	presented	to	the	potential	participant	
during	an	information	session,	where	one	of	the	investigators	detailed	all	aspects	of	the	
study	including	procedures,	risks,	benefits,	anonymity	and	confidentiality,	
compensation	($225/participant),	freedom	to	withdraw	from	the	study	at	any	time,	
approval	of	research	and	participant	responsibilities.		
	
Randomization	
Participants	were	randomized	in	a	double	blind	fashion	to	the	blueberry	(n=10)	
or	placebo	group	(n=11).	
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Participant	Visits	and	Timeline	
Visit	1	took	take	place	24-hours	after	the	information	session	detailed	in	the	
above	“Informed	Consent”	description.		Visit	1	consisted	of	reading	and	signing	the	
informed	consent,	medical	screening	(Appendix	C),	diet	instruction	and	body	
composition	assessment	(height,	weight,	DEXA)	immediately	followed	by	blood	draw,	
muscle	biopsy	and	strength	measurements.		Upon	completion	of	Visit	1,	participants	
began	6-weeks	of	daily	supplementation.			
Participants	reported	back	to	the	laboratory	for	Visit	2	six	weeks	later.		During	
this	visit,	body	composition	measures	were	repeated,	diet	history	information	was	
collected	and	reviewed	as	needed	with	participants,	and	blood	and	muscle	samples	
were	obtained	in	a	similar	fashion	to	Visit	1.		Following	blood	and	muscle	samples,	
participants	underwent	mechanically-induced	muscle	damage	as	a	stimulus	for	
regeneration	(see	section,	Mechanically	Induced	Muscle	Damage).		Visit	3	occurred	24-
hours	after	the	muscle	regenerative	stimulus,	when	final	blood	and	muscle	samples	
were	obtained.		
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Blueberry/Placebo	Supplementation	
The	supplementation	protocol	consisted	of	participants	ingesting	a	total	of	38	
grams	per	day	of	100%	freeze-dried	blueberry	powder	(equivalent	to	250g	of	whole	
blueberries)	or	the	equivalent	gram	amounts	of	placebo	packets	daily	for	6-weeks.		
Packets	were	apportioned	into	labeled	week-by-week	bags.		Participants	were	blinded	
to	the	assignment.		Packet	contents	were	not	discernable	from	one	another.		
Participants	were	instructed	to	consume	packets	with	8-ounces	of	water	with	the	
evening	meal.		See	Appendix	D	for	detailed	instructions	concerning	packet	
•Informed	Consent
•Medical	Screen
•Baseline	Diet	Record	instruction	(three	days	the	first	week	and	three	
days	the	final	week)
•Anthropometrics	 (height,	weight,	%	body	fat	- DEXA)
•Blood	draw,	muscle	biospy,	strength	measures
Orientation/	
Study	Visit	1	
(90	Minutes)
•Subjects	consume	blueberry	powder	or	placebo	with	evening	meal,	
daily	for	six	weeks.	
6-Weeks	
Supplementation	
Period
•Diet	record	reviewed	with	participant	
•Anthropometrics	 (height,	weight,	%	body	fat	- DEXA)
•Blood	draw,	muscle	biopsy	followed	by	muscle	regenerative	stimulus
Post-supplementation	
Study	Visit	2
(90	Minutes)
•Blood	draw	and	muscle	biopsy	24-hours	post-muscle	regenerative	
stimulus
Post-supplementation	
Study	Visit	3
(90	Minutes)
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consumption.		Participants	were	instructed	to	return	supplement	packaging,	empty	or	
otherwise,	to	its	respective	weekly	bag	for	return	at	the	conclusion	of	the	study.		Upon	
return,	packets	were	inventoried	to	determine	compliance.		Compliance	was	further	
measured	via	weekly	e-mail/phone	correspondence.		Participants	were	also	asked	to	
answer	questions	based	on	their	experiences	during	the	supplementation	period.		
Answers	to	these	questions	were	returned	and	compiled	at	the	conclusion	of	the	study	
(Appendix	D).	
	
Body	Composition	Assessment	
Measures	of	body	composition	were	obtained	by	determining	each	participant’s	
height	in	the	Frankfurt	position	using	a	stadiometer34	weight	using	a	digital	scale35	and	
muscle/fat	mass	by	a	physician	prescribed	Dual	Emission	X-ray	Absorptiometry	(DEXA)	
scan36	on	each	participant	at	Visits	1	and	2.	
	
Diet	Education/Analysis	
Each	participant	was	informed	on	how	and	when	to	accurately	record	dietary	
intake	on	a	three-day	diet	record	(Appendix	F	and	G)	during	the	first	and	final	week	of	
supplementation.		On	Visit	2,	the	returned	diet	records	were	reviewed	with	participant	
to	ensure	completeness	and	clarity.		Data	from	diet	records	were	entered	into	diet	
analysis	software37	and	examined	for	total	calories,	carbohydrate,	protein,	fat,	and	
select	antioxidant	micronutrients	(vitamin	A,	vitamin	E,	vitamin	C,	copper,	manganese,	
selenium,	and	zinc).		Detailed	printouts	of	nutrient	intake	were	compared	to	written	
entries	by	another	member	of	the	research	team	to	identify	errors	in	entry	and	ensure	
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accurate	data	entry.		Data	from	three-day	diet	records	were	analyzed	to	determine	
differences	in	dietary	intake	within	and	between	groups	at	baseline	and	6-weeks	post-
supplementation.		
	
Strength	Measurements**		
(**	Denotes	procedure	or	analysis	carried	out	by	Exercise	Science	researchers)	
Prior	to	experimental	procedures,	participants’	knee	extension	1	–	repetition	
maximum	was	determined	according	to	protocol	designed	by	faculty	within	the	
Exercise	Science	Department	according	to	a	predetermined	protocol.		The	resulting	
measure	was	used	to	calculate	subsequent	stimulus	needed	for	mechanically-induced	
muscle	damage.	
	
Mechanically	Induced	Muscle	Damage**	
Participants	executed	a	series	of	resistance	exercises	in	order	to	force	volitional	
fatigue.		This	was	carried	out	under	the	supervision	of	researchers	from	the	Exercise	
Science	department	according	to	a	predetermined	protocol.	
	
Blood	and	Tissue	Collection**	
Muscle	biopsies	and	blood	draws	were	completed	in	the	morning	after	an	
overnight	fast.		Blood	samples	were	obtained	from	the	antecubital	vein	by	a	qualified	
phlebotomist.		Plasma	was	isolated	from	whole	blood	by	centrifugation	and	stored	at	-
80°C.		Muscle	samples	were	obtained	under	local	anesthetic	(1%	lidocaine)	from	the	
vastus	lateralis	by	percutaneous	needle	biopsy	by	a	qualified	professional,	under	the	
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supervision	of	a	licensed	physician.		Participants	were	supplied	with	a	handout	
detailing	how	to	care	for	the	site	of	the	biopsy	(Appendix	H).		Muscle	samples	were	snap	
frozen	in	liquid	nitrogen	and	stored	at	-80°C	for	analysis	by	Exercise	Science	
researchers	according	to	a	predetermined	protocol.	
	
Sample	Analysis/Assays		
Total	antioxidant	capacity	of	the	plasma	was	determined	for	each	sample,	from	
each	visit,	by	measuring	FRAP	(ferric	reducing	ability	of	plasma)	and	oxidative	damage	
assessed	by	measurement	of	8-Isoprostane	(Appendix	I	and	J).	
	
FRAP	
Total	plasma	antioxidant	potential	was	determined	by	the	FRAP	assay	according	
to	the	methodology	of	Benzie	and	Strain	[1].		The	basis	of	this	assay	is	that	water	
soluble	reducing	agents	(antioxidants)	in	the	plasma	will	reduce	ferric	ions	to	ferrous	
ions,	which	then	react	with	an	added	chromogen.		Working	FRAP	solution	was	prepared	
daily	and	consisted	of	300	mmol/L	acetate	buffer	with	the	pH	adjusted	to	3.6	(3.1	g	
sodium	acetate	[Sigma,	St.	Louis,	MO,	USA]	and	16	mL	od	1N	acetic	acid	[Sigma]	per	liter	
of	buffer	solution);	10	mmol/L	2,4,6-tripyridyl-s-triazine	(TPTZ)	[Sigma]	in	40	mmol	
hydrochloric	acid	(HCl)	[Fisher	Scientific,	Pittsburgh,	PA,	USA];	20	mmol	iron	
trichloride	hexhydrate	(ITX)	[Sigma]	in	doubly	distilled	deionized	water.		Working	
FRAP	reagent	was	prepared	as	required	by	mixing	25	mL	acetate	buffer,	2.5	mL	ITX	
solution,	and	2.5	mL	TPTZ	solution.		The	working	FRAP	solution	was	placed	in	a	water	
bath	and	warmed	to	37°	C.		Then,	10	µL	of	blank,	samples,	and	ascorbate	STDs	were	
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transferred	by	micropipette	into	designated	well	of	96	well	plate.		Three	hundred	µL	of	
FRAP	reagent	was	then	added	to	all	wells	containing	blank,	samples,	and	STDs.		The	96	
well	plate	was	then	incubated	for	4	minutes	at	37°	C	before	being	read	at	593	nm	in	a	
spectrophotometer	(Genesys-5;	Thermo	Spectronic,	Rochester,	NY,	USA).		Samples	and	
standards	were	analyzed	in	triplicate,	and	FRAP	values	were	expressed	as	vitamin	C	
equivalents	as	determined	by	linear	regression	from	a	vitamin	C	curve	(0-1000	µmol).	
	
F2-Isoprostanes	
The	Express	ELISA	Kit	(Cayman	Chemical	Company,	Ann	Arbor,	MI)	was	used	
according	to	the	manufacturer's	instructions.		The	8-IP	assay	was	based	on	the	principle	
of	competitive	binding	between	sample	8-IP,	8-IP	acetyl	cholinesterase	(AChE)	
conjugate,	and	8-IP	tracer	for	a	limited	number	of	8-IP-specific	rabbit	anti-serum	
binding	sites.		Fifty	microliters	of	sample	was	added	to	each	well,	and	50	µL	of	8-IP	
AChE	tracer	was	added	to	all	wells	except	total	activity	and	blank	wells.		Fifty	
microliters	of	8-IP	enzyme-immunoassay	antiserum	was	added	to	all	wells	except	total	
activity,	nonspecific	binding,	and	blank	wells.		The	plates	were	covered	and	incubated	at	
4°C	for	18	h	and	then	washed	5	times	with	buffer.		Two	hundred	microliters	of	Ellman's	
reagent	was	added	to	each	well,	and	50	µL	of	tracer	was	added	to	total	activity	wells	
only.		Plates	were	covered	with	plastic	films	for	90	min,	and	absorbance	was	read	at	
420	nm.	The	amount	of	8-IP	tracer	bound	was	inversely	proportional	to	the	
concentration	of	8-IP	in	the	sample.	
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Statistical	Analysis	
Statistical	design	was	a	2	treatment	x	3	times	repeated	measures	ANOVA	for	
main	variables	of	FRAP	and	F2-isoprostanes	using	SPSS	(IBM®	SPSS©	Version	22).		
Descriptive	measures	were	compared	using	a	paired	t-test.		All	values	are	mean	+SD.	 	
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RESULTS	
	
	
General	participant	characteristics	are	shown	in	the	Table	1.		Age,	height,	weight,	
and	body	mass	index	were	not	different	between	groups.		Plasma	redox	status	was	not	
affected	by	treatment,	time,	or	treatment-time	interactions	as	FRAP	values	(treatment,	
P	=	0.065;	time,	P	=	0.532;	treatment-time,	P	=	0.428)	did	not	exhibit	significant	
differences	between	groups	(Figure	1).		However,	an	increasing	trend	was	observed	for	
treatment	(P	=	0.065).		Similarly,	oxidative	damage	by	measure	of	plasma	levels	of	F2-
Isoprostanes	did	not	differ	between	groups	for	treatment,	time,	or	treatment-time	
interactions	(treatment,	P	=	0.252;	time,	P	=	0.482;	treatment-time,	P	=	0.084)	(Figure	
2).		However,	a	trend	was	observed	for	treatment-time	interaction	(P	=	0.084).		
No	significant	differences	were	observed	in	diet	(total	calories,	carbohydrate,	protein,	
fat,	vitamin	A,	vitamin	E,	vitamin	C,	copper,	manganese,	selenium,	and	zinc)	between	or	
within	groups	before	or	after	treatment,	with	the	exception	of	higher	vitamin	C	and	
selenium	levels	pre-BB	(Raw	data	for	participant	diet	records	are	presented	in	Appendix	
K	).	These	higher	intakes,	however,	did	not	affect	measures	of	plasma	redox.	
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Table	1.		Participant	Descriptives.		Data	are	Mean	+	SD.	
	
	
	
	
	
Figure	1.	Ferric	Reducing	Ability	of	Plasma	(FRAP).		Data	are	Mean	+	SD	
(treatment,	P	=	0.065;	time,	P	=	0.532;	treatment-time,	P	=	0.428)	
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Figure	2.		F2-isoprostanes.		Data	are	Mean	+	SD.	
(treatment,	P	=	0.252;	time,	P	=	0.482;	treatment-time,	P	=	0.084)	
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DISCUSSION	
	
	
	
The	findings	of	this	study	show	that	six	weeks	daily	ingestion	of	freeze	dried	
blueberry	powder	(equivalent	to	250	g	rehydrated	berries)	did	not	have	a	significant	
effect	on	antioxidant	capacity	or	oxidative	damage	in	aged	skeletal	muscle.		A	limitation	
to	this	study,	similar	to	the	majority	of	human	intervention	studies,	was	low	statistical	
power	as	a	result	of	low	participant	numbers.		Another	potential	limitation	of	the	study	
was	the	relative	homogeneity	of	the	participants.		All	participants	of	the	study	were	
white,	non-Hispanic	and	predominantly	female.	In	healthy	muscle,	amino	acids	and	
proteins	are	held	in	a	relative	balance	between	their	breakdown	and	synthesis.		In	the	
muscle	of	the	elderly,	this	balance	is	disturbed	due	to	decreased	myogenesis	and	an	
increased	breakdown	of	myofibril	and	mitochondrial	proteins.		As	mentioned	earlier,	it	
has	been	hypothesized	that	the	onset	and	exacerbation	of	sarcopenia	could	be	due	in	
part	to	a	low-grade	chronic	state	of	inflammation	that	increases	linearly	with	age.		In	
addition	to	improper	and	inadequate	healing	from	muscle	related	injuries,	part	of	the	
reasoning	behind	this	could	in	part	be	due	to	a	reduction	in	food	intake	that	often	
accompanies	increasing	age.			
Therefore,	the	idea	of	exogenous	antioxidant	supplementation	in	addition	to	the	
diet	of	older	adults	could	prove	to	be	a	promising	treatment	in	correcting	dietary	
inadequacies	and	counteract	the	increased	protein	catabolism	leading	to	skeletal	
muscle	decline.2		A	study	by	Khan	et	al.38	examined	the	effects	of	dietary	intake	of	a	
blackcurrant	juice	drink,	rich	in	vitamin	C	and	polyphenols,	on	oxidative	stress	and	
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vascular	function.		In	this	double-blind,	placebo-controlled,	parallel	group	study,	66	
healthy	adults	(mean	age	of	53	years)	with	low	fruit	and	vegetable	intake	were	
randomly	assigned	to	consume	250ml	of	placebo,	low	blackcurrant	juice,	or	high	
blackcurrant	juice	drink	four	times	a	day	for	6	weeks.		Flow-mediated	dilation	(FMD),	
plasma	concentrations	of	F2-Isoprostane,	and	vitamin	C	were	measured.			
Results	of	the	study	indicated	that	the	high	and	low	blackcurrant	groups	FMD	
and	vitamin	C	concentration	increased	significantly	compared	with	the	placebo	group.		
F2-Isoprostane	concentrations	were	significantly	lower	in	the	high	blackcurrant	juice	
drink	group,	compared	with	the	low	blackcurrant	juice	drink	and	placebo	group.		
Results	of	this	study	provided	support	that	consumption	of	blackcurrant	juice,	high	in	
vitamin	C	and	polyphenols,	can	decrease	oxidative	stress	and	improve	vascular	health	
in	individuals	with	habitually	low	dietary	fruit	and	vegetable	intake.	Another	study	by	
McAnulty	et	al.39	observed	the	effect	of	blueberry	ingestion	on	natural	killer	cells,	
oxidative	stress	and	inflammation	on	25	well	trained	participants,	before	and	after	2.5	
hours	of	running.		Participants	in	the	study	were	divided	into	two	groups,	blueberry	
and	control.		The	blueberry	group	was	provided	with	and	asked	to	consume	250g	of	
whole	blueberries	per	day	for	6	weeks	and	a	larger	dose	consumed	one	hour	before	
running	2.5	hours	at	~72%	of	maximum	oxygen	consumption.		Blood	and	urine	samples	
were	obtained	pre-	and	immediately	post-	exercise	and	then	again	one	hour	later.		
Blood	was	examined	for	F₂-isoprostanes,	cortisol,	cytokines,	homocysteine,	leukocytes,	
T-cell	function,	natural	killer	(NK),	lymphocyte	cell	counts,	and	ferric	reducing	ability	of	
plasma.			
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Results	of	this	study	showed	increases	in	F₂-isoprostanes	to	be	significantly	less	
in	the	blueberry	group	compared	to	the	control	group.		Further,	plasma	IL-10	and	NK	
cell	counts	were	significantly	greater	in	blueberry	vs.	control.		Other	markers	did	not	
differ.		The	results	of	this	study	indicate	that	daily	blueberry	consumption	for	6	weeks	
increases	NK	cell	counts,	and	acute	ingestion	reduces	oxidative	stress	and	increases	
anti-inflammatory	cytokines.		
	Lynn	and	colleagues40	investigated	the	effect	of	a	tart	cherry	juice	supplement	
on	arterial	stiffness	and	inflammation	in	healthy	adults	aged	30-50	years.		In	this	
randomized	control	trial,	participants	consumed	30	ml	of	cherry	concentrate	diluted	to	
a	volume	of	250	ml	with	water	or	the	same	volume	of	an	energy	matched	control	drink	
daily	for	six	weeks.		At	each	of	the	visits,	pulse	wave	velocity,	systolic	blood	pressure	
(SBP),	diastolic	blood	pressure	(DBP)	and	body	weight	were	measured	and	a	blood	
sample	was	obtained.		Blood	was	examined	for	the	determination	of	total	cholesterol,	
high	density	lipoprotein	(HDL)	cholesterol,	CRP	and	total	antioxidant	activity	(ferric	
reducing	ability	of	plasma;	FRAP).		The	study	concluded	that	there	was	no	effect	of	the	
intervention	on	arterial	stiffness,	CRP,	SBP,	DBP,	total	cholesterol	and	HDL	cholesterol.		
However,	antioxidant	capacity	(FRAP)	was	significantly	higher	in	the	intervention	
group	than	the	control	group.		The	study	therefore	concluded	that	a	tart	cherry	juice	
concentrate,	rich	in	anthocyanins	had	no	effect	on	arterial	stiffness,	CRP	and	risk	
markers	for	cardiovascular	disease,	but	evokes	an	increase	in	antioxidant	status	in	
healthy	adults.		
Notwithstanding	the	overwhelming	clinical	significance	of	sarcopenia	and	great	
interest	for	antioxidant	supplementation,	the	amount	of	clinical	evidence	available	is	
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limited	and	somewhat	acrimonious.		This	could	in	part	be	due	to	the	fact	that	there	is	no	
clinical	definition	for	sarcopenia.		The	majority	of	studies	conducted,	investigating	
physical	performance	and	antioxidant	supplementation,	have	focused	on	measures	of	
muscular	strength	and	protection	from	athletic	injuries	without	exclusively	examining	
sarcopenia	and	muscle	loss	in	the	geriatric	population.		For	example,	Jakeman	and	
colleagues41	observed	vitamin	C	supplementation	to	have	a	protective	effect	against	
exercise-induced	muscle	damage.	Resveratrol,	found	in	berries,	grapes,	and	peanuts	is	a	
polyphenol	that	has	been	shown	to	attenuate	oxidative	stress	in	skeletal	muscle	by	
expression	of	antioxidant	enzymes.42		Another	study	by	Ryan	and	colleagues43	showed	
that	after	more	than	four	weeks	of	training,	vitamin	C	and	E	supplementation	was	able	
to	reduce	muscular	levels	of	oxidative	stress	in	the	muscles	of	repetitively	loaded	older	
mice;	however,	no	increase	in	muscle	mass	or	maximal	force	production	was	observed.		
Conversely,	there	are	several	studies	that	have	shown	the	potential	negative	effects	of	
antioxidant	supplementation.		One	study	by	Strobel	et	al.44	showed	that	after	14	weeks	
of	vitamin	E	and	α-lipoic	acid	supplementation,	post-treatment	antioxidant	levels	were	
actually	decreased	from	baseline	levels.		Several	other	studies	showed	there	to	be	no	
effect	at	all.		Theodorou	et	al45	found	no	significant	effect	on	muscle	performance	after	
supplementing	with	ascorbic	acid	and	tocopherol.	Similarly,	a	study	that	examined	
mitigating	signs	of	premature	aging	(muscle	wasting,	joint	ossification,	corneal	
inflammation,	cataracts)	in	BMAL1	knockout	mice	with	N-acetyl-L-cysteine,	resulted	in	
a	slightly	extended	lifespan	but	had	no	significant	effect	on	sarcopenia.46	
There	are	several	potential	reasons	for	the	inconsistencies	in	the	results	of	these	
studies	attempting	to	shine	light	on	whether	antioxidant	supplementation	can	have	a	
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beneficial	effect	on	age-related	muscle	wasting.		On	the	one	hand,	it	is	possible	that	
sarcopenia	and	oxidative	damage	are	entirely	independent	of	each	other.		It	is	also	
important	to	note	that	when	testing	interventions	in	the	geriatric	population,	it	is	very	
difficult	to	obtain	a	truly	homogeneous	pool	of	participants.		Due	to	the	general	novelty	
of	this	field	of	study,	there	is	a	dearth	of	experiments	with	similar	methodologies	for	
use	of	comparison.		Variations	in	the	type	and	dose	of	antioxidants	administered	as	well	
as	the	timing	of	supplementation	and	methods	used	to	measure	antioxidant	biomarkers	
in	vivo	are	all	exceptionally	inconsistent	in	the	literature.			
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CONCLUSION	
	
	
In	conclusion,	ingestion	of	freeze	dried	blueberry	powder	(equivalent	to	250	g	
rehydrated	berries)	did	not	have	a	significant	effect	on	antioxidant	capacity	or	oxidative	
damage	on	aged	skeletal	muscle.		Trends	were	observed	for	plasma	redox	status,	
treatment	(P	=	0.065)	and	F2-Isoprostanes,	treatment-time	(P	=	0.084)	lending	to	the	
idea	that	perhaps	future	studies	should	examine	more	closely	the	acute	effects	of	
antioxidant	supplementation	with	blueberries	on	plasma	redox	and	oxidative	damage.		
Therefore,	at	this	time,	we	reject	our	hypothesis	that	blueberry	consumption	has	a	
statistically	significant	benefit	on	antioxidant	capacity	and	inflammation	in	relation	to	
sarcopenia	in	older	adults.		Theoretically,	as	the	concentration	of	antioxidants	in	the	
blood	rises,	an	inverse	effect	on	F2-Isoprostanes	would	be	observed,	therefore	offering	a	
protective	effect	against	oxidative	damage.		However,	the	results	of	this	study	proved	to	
be	inconsistent	with	this	theory.	
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Researchers	with	Appalachian	State	University’s	College	
of	Health	Sciences	are	looking	for	moderately	active	men	
and	women	over	60	years	old	to	participate	in	a	study	to	
help	determine	ways	to	improve	muscle	health.		
Participants	will	be	required	to	attend	1	visit	on	campus	
followed	by	a	6-week	long	blueberry	supplementation	
intervention	and	2	subsequent	visits.			
Participants	will	gain	valuable	information	about	their	
health	and	be	compensated	$225	(upon	completion	of	the	
study)	for	their	time	and	effort.	
	If	you	are	interested	in	learning	more	about	this	research	
study,	please	contact	Edward	Merritt,	Ph.D.	by	e-mail	at	
merrittek@appstate.edu.	
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Consent to Participate in Research 
Information to Consider About this Research 
 
 
The influence of blueberry consumption on the muscular health of older 
adults. 
 
Principal Investigator: Edward Merritt, Ph.D. 
Department: Health and Exercise Science 
Contact Information: ASU Box 32071 Boone, NC  28608 
            merrittek@appstate.edu 
            205-262-7986 
This research is funded by: U.S. Highbush Blueberry Council 
 
What is the purpose of this research? 
 
The purpose of this research study is to determine how daily blueberry consumption 
affects the muscular health of older adults. 
 
Why am I being invited to take part in this research?  
 
You are being invited to participate in this research study because you are over 60 
years old, a non-smoker, not participating in any regular exercise program, and are 
considered a healthy weight and not actively trying to gain or lose weight, but are 
otherwise considered healthy. 
 
Are there reasons I should not take part in this research? 
 
If you have a history of cardiovascular, pulmonary, metabolic, or neuromuscular 
diseases you should not participate in this study. If you have had a lower body 
musculoskeletal injury in the previous 6 months or have an inflammatory disorder 
such as rheumatoid or osteoarthritis, you should not participate in this study. If you 
are currently undergoing any type of hormone therapy, taking prescription anti-
inflammatories or anti-coagulants, you should not participate in this study. 
Additionally, you cannot participate in this study if you are allergic to the local 
anesthetic, lidocaine or if you have an intolerance or allergy to blueberries. 
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What will I be asked to do? 
 
If you agree to participate you will need to complete one information session and 
three study visits over the course of the next 6+ weeks. Each study visit will require 
you to be fasted (no food or drink other than water for 12 hours prior to the study 
visit) and will take approximately 90 minutes. The total amount of time you will be 
asked to volunteer for this study is five hours over the course of one 6-week period, 
although this estimate does not include the time it will take you to mix and consume 
your supplement (twice daily for 6 weeks) or complete your diet record (~ 10 
minutes/day for 3 days during the first and last week of your study enrollment).  
 
You are now partaking in the orientation and information session, which consists of 
thoroughly reading this form and asking any questions you have about the research 
study. 
 
During your Study Visit 1, at least 24 hours after the information session, you will 
complete a health history questionnaire.  Your height and weight will be recorded 
and resting heart rate and blood pressure will be measured. If you are still eligible to 
participate, you will then have a dual energy x-ray absorptiometry (DEXA) scan to 
determine your body composition. You will have to lie perfectly still on the machine 
for approximately five minutes. Immediately following the DEXA scan, you will 
perform a maximal strength test, followed by a blood draw and a muscle biopsy 
(described below). If you take aspirin on a regular basis, we ask that you do not take 
it 48 hours before or after the muscle biopsies, because it can lead to excessive 
bleeding and bruising (One biopsy will be done during each study visit).You will be 
randomly assigned to the blueberry supplement or placebo supplement group and 
begin 6-weeks of daily supplementation following Visit 1. We will provide you with a 
supply of the supplement or placebo at this visit. You will also be given instructions 
on how to keep a 3-day diet record and asked to do so during the first and last week 
of supplementation.  You agree not to initiate a formal exercise program and 
maintain your normal diet over the course of the 6-weeks.   
You will report back to the lab after the 6 weeks of supplementation for Visit 2. 
During this visit body composition measures, diet history, and blood and muscle 
samples will be obtained before you undergo a muscle stress stimulus (described 
below). Visit 3 will occur 24-hours after the muscle stress stimulus. The final blood 
and muscle samples will be obtained at this time. 
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Subject	Timeline:	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 
 
 
 
 
 
 
 
 
 
 
Strength Measurements (Study Visit 1) 
 
Prior to supplementation and other experimental procedures, your knee extension 1- 
repetition maximum strength will be determined. After a 5 minute warm-up on the 
treadmill or stationary bike, your maximum voluntary contraction knee extension 
force will be measured using a Cybex knee extension machine. The resulting force 
output will be used to calculate the subsequent stimulus needed for mechanically-
induced muscle damage. 
 
 
 
 
 
 
 
 
Orientation/  
Study Visit 1 
(90 minutes) 
6-wk 
supplementation 
period 
Post-
supplementation 
Study Visits 2 & 3 
(90 minutes each) 
1.	Informed	Consent	
2.	Medical	Screen		
3.	Baseline	Diet	Record	
Instruction	(M,	W,	and	
Sat	Prior	to	
supplementation)	
4.	Physical	
measurements	(height,	
weight,	%	body	fat	
(DEXA)	
5.		Blood	draw,	muscle	
biopsy,	strength	
measures	
	
Subjects	
consume	
equivalent	of	
250g	per	day	of	
blueberry	
powder	or	
placebo.	
	
1.	Diet	Record	(M,	W,	
and	Sat	last	week	of	
supplementation)	
2.	Physical	
measurements	
(weight,	%	body	fat	
(DEXA)	
3.	Blood	draw,	muscle	
biopsy	followed	by	
muscle	stress	stimulus	
4.	Visit	3.	Blood	&	
Muscle	biopsy	24-
hours	post-muscle	
stress	stimulus	
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Blueberry/Placebo Supplementation 
 
Depending on your randomly assigned group, you will be ingesting either 100% 
blueberry powder made from freeze-dried, crushed whole blueberries (two, 18 gram 
servings of powder mixed with water per day, which is equivalent to 1.7 cups, ~145 
whole blueberries, or placebo powder (a powder composed of carbohydrates and 
natural coloring with the same amount of calories as the blueberry powder) mixed 
with water daily for 6 weeks. The freeze-dried blueberries and placebo powder will 
be supplied by Mercer Foods and the U.S. Highbush Blueberry Council. You will not 
know whether or not you have received the blueberry or placebo powder. A 6-week 
supply in individual packets (~18 grams of powder) will be provided to you during 
your first study visit. You will mix the packet with 1-2 cups of water and consume one 
packet in the morning and one in the evening. If you forget to take the packet, there 
is no need to double your dose for the next time, just continue as normal. You will 
return any unused packets at the end of the 6-week period.  
 
Mechanically-Induced Muscle Damage (Study Visit 2) 
 
You will perform knee extensions against weight equal to 60% of your previously 
determined 1-repetition maximum. You will perform 8-12 of these exercises per set 
for a total of 9 sets with one minute rest between each set. 
 
Tissue Collection (Study Visits 1, 2, 3) 
 
Muscle biopsies and blood draws will be performed 3 total times (Study Visits 1, 2, 
and 3) in the morning, at least 12 hours after the last meal, prior to supplementation, 
following 6 weeks of supplementation and prior to induced muscle damage, and 24 
hours post-muscle damage. For blood sampling, we will withdraw six teaspoons of 
blood from a vein near the crease of your elbow. For muscle sampling, we will numb 
the area with a local anesthetic (lidocaine), and we will remove a muscle sample 
(approximately the size of a pencil eraser) from your thigh using a needle designed 
for this purpose.	You are free to bring a snack to each study visit in case you would 
like to eat after the blood draw and muscle sample collection. At the end of each 
visit, you will be briefed on how to care for the muscle biopsy site and also given a 
care sheet with information on how to care for the site and who to contact should 
you have any questions. 
All research activities will take place in Appalachian State University’s University Hall 
and Holmes Convocation Center in the Department of Health, Leisure, and Exercise 
Science’s Neuromuscular and Exercise Science Laboratories. You will be provided 
with a temporary parking pass on the days of your study visits. 
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What are possible harms or discomforts that I might experience during the 
research? 
 
You will be carefully screened at the beginning of this study to determine if you can 
participate safely, but should you choose to participate in this research study there 
are some risks and discomforts associated with the procedures. 
 
• Maximum strength tests are considered safe for apparently healthy individuals, 
but there are some minimal risks associated with maximal strength testing. You 
might experience dizziness and lightheadedness during or for a short time after 
exercise. These symptoms should subside within 2-3 minutes. To minimize 
these risks, you will be monitored by research personnel at all times before, 
during, and until all symptoms have resolved after the test. You might also feel 
fatigued immediately after testing and might experience muscle soreness in the 
days following the maximal testing. These symptoms should resolve without 
any treatment. 
 
• The risks associated with a DEXA scan include exposure to small amounts of 
radiation.  DEXA scanning utilizes radiation to obtain an image of your body.  
Everyone receives a small amount of unavoidable radiation from the 
environment each year. Some of this radiation comes from space and some 
from naturally-occurring forms of radioactive water and minerals. The DEXA 
scan technique gives your body the equivalent of about 4 extra days’ worth of 
this natural radiation. The radiation dose we have discussed is what you will 
receive from this study only and does not include any exposure you may have 
received or will receive from other tests.  If you are pregnant or trying to get 
pregnant, you should not participate in a DEXA scan. 
 
• The risks of collecting a blood sample (via venipuncture) from include the 
possibility of local discomfort (slight pinch when the needle enters their skin), 
minor bruising or bleeding at the site (10%), possible temporary 
lightheadedness, infection (<0.01%), or development of a blood clot 
(<0.01%). The amount of blood being withdrawn is about 6 teaspoons and will 
not influence the ability to participate in normal daily activities. A trained and 
experienced individual will perform the technique and the blood will be 
collected in a hygienic setting with sterile materials and biohazard protection 
measures to minimize these risks.   
 
• There are some risks associated with the skeletal muscle biopsy technique. 
These risks may include slight discomfort with pressure or “tugging” 
sensations; however, most of the discomfort will subside 1-2 days after the 
technique. The use of a local anesthetic (numbing agent) will help minimize 
these risks. You may experience some mild discomfort (burning or stinging) 
when the local anesthetic is injected (before the area becomes numb). There 
is an extremely small risk that you will have an allergic reaction to the local 
anesthetic. If you have a history of allergies to local anesthetics then you 
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cannot participate in the study. Other risks associated with the muscle biopsy 
technique include bleeding at the biopsy site, temporary lightheadedness, 
infection (approximately 1 in 2,000), and bruising of the area (approximately 1 
in 4,000).Using sterile materials/techniques and applying a cold compress 
and pressure to the biopsy site will minimize these risks. The muscle biopsy 
incision site will be closed by a steri-strip or stitches. If stitches are used, you 
will need to return to the lab to have your stitches removed. You will be given 
a checklist of symptoms to watch for and asked to report the occurrence of 
any of the symptoms immediately to the research staff. You will be asked to 
seek medical attention if you have any of the symptoms on the list. All muscle 
biopsy procedures will be performed under sterile conditions in a hygienic 
setting with biohazard protections. In the rare case of exposure of blood or 
tissue to research personnel, testing will be conducted for HIV and hepatitis 
(a positive HIV or hepatitis test will be reported to you). 
 
• The risks associated with the muscle stress stimulus are similar to the risks of 
maximal muscle strength testing. The muscle stress stimulus consists of 
multiple repetitions (8-12) and multiple sets (9) of a standard isotonic, knee 
extension exercises. You might experience dizziness and lightheadedness 
during or for a short time after exercise. These symptoms should subside 
within 2-3 minutes. To minimize these risks, you will be monitored by 
research personnel at all times before, during, and until all symptoms have 
resolved after the test. You might also feel fatigued during and immediately 
after testing and will likely experience muscle soreness in the days following 
the protocol. These symptoms should resolve without any intervention. 
 
• Dietary supplements contain a variety of ingredients, such as vitamins, 
minerals, amino acids, and herbs or other botanicals.  To use dietary 
supplements safely, read and follow the label instructions, and recognize that 
"natural" does not always mean "safe".  Some dietary supplements may 
interact with medications or pose risks if you have medical problems or are 
going to have surgery.  Most dietary supplements have not been tested in 
pregnant women, nursing mothers, or children.  The U.S. Food and Drug 
Administration (FDA) regulates dietary supplements, but the regulations for 
dietary supplements are different and less strict than those for prescription or 
over-the-counter drugs.  Tell all your health care providers about any 
complementary health approaches you use.  Give them a full picture of what 
you do to manage your health.  This will help ensure coordinated and safe 
care.  
 
What are possible benefits of this research? 
 
By participating in this research, you might personally benefit by learning about your 
body composition. The information gained from this study might also lead to 
recommendations to improve the muscular health of older adults. 
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Will I be paid for taking part in the research? 
 
You will receive $225 for completing all phases of this research study. Should you 
have to withdraw before completion of the study, your compensation will be prorated 
and you will be paid $75 per study visit completed. 
 
What if I get sick or hurt while participating in this research study?  
 
• If you need emergency care while you are at the research site, it will be 
provided to you. If you get hurt or sick when you are not at the research site, 
you should call your doctor or call 911 in an emergency. If your illness or 
injury could be related to the research, tell the doctors or emergency room 
staff about the research study, the name of the Principal Investigator and 
study physician, and provide a copy of this consent form if possible. Call the 
principal investigator, Edward Merritt, at (828)-262-7986, and the study 
physician, Dr. Cate Trate, at (828) 264-7760. They need to know that you are 
hurt or ill.    
 
• There are procedures in place to help attend to your injuries or provide care 
for you.  Costs associated with this care will be billed in the ordinary manner, 
to you or your insurance company. However, insurance companies, 
Medicare, and Medicaid might not pay bills that are related to research costs. 
You should check with your insurance about this and talk to the Principal 
Investigator if you have concerns. 
 
How will you keep my private information confidential? 
 
• Your information will be combined with information from other people taking 
part in the study. When we write up the study to share it with other 
researchers, we will write about the combined information. You will not be 
identified in any published or presented materials. To ensure that your 
information is kept confidential, identification numbers but not names will be 
used on all documents. All data entry and analysis will be conducted with 
statistical programs using identification. Your files will be stored in Dr. Merritt’s 
office under lock and key and identifiable information will be deleted after one 
year.   
 
After completion of this research study remaining serum and muscle samples 
collected during the experiment as described above will be stored, with your 
permission for use in future research studies on muscle physiology. All samples will 
be coded and only research staff will have access to the code identifiers which will 
be stored securely. Your serum and muscle samples, but no identifying information, 
might be shared with other research laboratories and investigators studying muscle 
physiology. If your samples are used for future research, you will not be contacted 
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for additional consent. Research results from your samples will be published in 
medical and scientific journals, but your identity will not be revealed. Your samples 
will not be used for commercial gain. There are no additional foreseeable risks or 
benefits if your samples are stored and used in future research studies. If you do not 
wish your samples to be used, following the completion of this study, they will be 
destroyed. 
 
Please initial your choice(s) below: 
 
____ I agree to allow my samples to be preserved for future research on muscle 
physiology. 
 
____ I do not agree to allow my samples to be preserved for future research on 
muscle physiology. 
 
Whom can I contact if I have a question? 
 
The people conducting this study will be available to answer any questions 
concerning this research, now or in the future.  You may contact the Principal 
Investigator, Edward Merritt, at (828) 296-7986. You may contact the study 
physician, Cate Trate, at (828) 264-7760. If you have questions about your rights as 
someone taking part in research, contact the Appalachian Institutional Review Board 
Administrator at 828-262-2692 (days), through email at irb@appstate.edu or at 
Appalachian State University, Office of Research and Sponsored Programs, IRB 
Administrator, Boone, NC 28608. 
Do I have to participate?   
 
No, your participation in this research is completely voluntary.  If you choose not to 
volunteer, there is no penalty or consequence.  If you decide to take part in the study 
you can still decide at any time that you no longer want to participate. You will not 
lose any benefits or rights you would normally have if you do not participate in the 
study. 
 
This research project has been approved on 8/28/2013 by the Institutional Review 
Board (IRB) at Appalachian State University.  This approval will expire on 4/15/2014 
unless the IRB renews the approval of this research. 
I have decided I want to take part in this research.  What should I do now? 
If you have read this form, had the opportunity to ask questions about the research 
and received satisfactory answers, and want to participate, then sign the consent 
form and keep a copy for your records.  
             
Participant's Name (PRINT)                                 Signature                            Date   
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Photography and Video Recording Authorization 
With your permission, still pictures (photos) and/or video recordings taken during the 
study may be used in research presentations of the research findings.  Please 
indicate whether or not you agree to having photos or videos used in research 
presentations by reviewing the authorization below and signing if you agree.   
 
 
Authorization 
 
I hereby release, discharge and agree to save harmless Appalachian State 
University, its successors, assigns, officers, employees or agents, any person(s) or 
corporation(s) for whom it might be acting, and any firm publishing and/or distributing 
any photograph or video footage produced as part of this research,  in whole or in 
part, as a finished product, from and against any liability as a result of any distortion, 
blurring, alteration, visual or auditory illusion, or use in composite form, either 
intentionally or otherwise, that may occur or be produced in the recording, 
processing, reproduction, publication or distribution of any photograph, videotape, or 
interview, even should the same subject me to ridicule, scandal, reproach, scorn or 
indignity. I hereby agree that the photographs and video footage may be used under 
the conditions stated herein without blurring my identifying characteristics.  
 
 
             
Participant's Name (PRINT)                                 Signature                           Date 
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APPENDIX	C	
Heath	and	Medical	History	Questionnaire		
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Subject ID: _______________________   Interviewer’s Name:__________________ 
Date	(mm/dd/yy):____________________	 	 	 	 	 	Birthdate	_______________	
HEALTH AND MEDICAL HISTORY QUESTIONNAIRE 
	
BACKGROUND 
1. What is your highest level of education? 
 __Elementary __Jr High School __High School  __College __Post 
College 
2. What is your ethnic background? 
 __Hispanic or Latino (Cuban, Mexican, Puerto Rican, South or Central American, or other 
Spanish origin) 
__Not Hispanic or Latino 
3. What is your race? __White (Europe, the Middle East, or North Africa) __ African 
American __ Asian   __ Native Hawaiian/Pacific Islander __ 
American Indian/Alaska Native 
OVERALL HEALTH 
4. How would you rate your present health condition? 
  __Poor  __Fair  __Good __Excellent 
5. Typically, how many days/year are you sick enough to stay in bed?___________ 
 
WEIGHT HISTORY 
6. Has your weight changed more than 10 lbs in the last 12 months? __Yes __No 
 If yes, why: 
 __change in diet __change in physical activity __illness __depression/stress
 __other 
7. Do you have a history of an eating disorder, such as anorexia or bulimia? __No __Yes 
8. Have you ever smoked? 
 __Never __Not now, but more than 12 months ago __Not now, but within the past 12 
months 
 __Yes, currently smoking 
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MEDICAL HISTORY 
9. Please check which of the following conditions you have had or now have.  Also check medical 
conditions in your  family (father, mother, brother(s), or sister(s)). Check as many as apply 
	 Personal Family  Medical History 
	 	 □	 □	 	 Coronary heart disease, heart attack 
  □	 □  Surgery 
	 	 □	 □	 	 Angina 
	 	 □	 □	 	 High blood pressure 
	 	 □	 □	 	 Peripheral vascular disease 
	 	 □	 □	 	 Phlebitis or emboli 
	 	 □	 □	 	 Other heart problems (specify:_________________) 
	 	 □	 □	 	 Lung cancer 
	 	 □	 □	 	 Breast cancer 
	 	 □	 □	 	 Prostate cancer 
	 	 □	 □	 	 Colorectal cancer 
	 	 □	 □	 	 Skin cancer 
	 	 □	 □	 	 Other cancer (specify:________________) 
	 	 □	 □	 	 Stroke 
	 	 □	 □	 	 Chronic obstructive pulmonary disease (emphysema) 
	 	 □	 □	 	 Pneumonia 
	 	 □	 □	 	 Asthma 
	 	 □	 □	 	 Bronchitis 
	 	 □	 □	 	 Diabetes mellitus 
	 	 □	 □	 	 Thyroid problems 
	 	 □	 □	 	 Kidney disease 
	 	 □	 □	 	 Liver disease (cirrhosis of the liver) 
	 	 □	 □	 	 Hepatitis (A,B,C,D, or E) 
	 	 □	 □	 	 Gallstones/gallbladder disease 
	 	 □	 □	 	 Osteoporosis 
	 	 □	 □	 	 Arthritis 
	 	 □	 □	 	 Gout 
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	 	 □	 □	 	 Anemia (low iron) 
	 	 □	 □	 	 Stomach/duodenal ulcer 
	 	 □	 □	 	 Rectal growth or bleeding 
	 	 □	 □	 	 Cataracts 
	 	 □	 □	 	 Glaucoma 
 	 □	 □	 	 Depression 
  □	 □	 	 Substance abuse problems (alcohol, drugs etc) 
 
10. Please indicate the approximate number of alcoholic beverages per every two weeks. (Beer: 
 one drink = one 12-ounce beer; Liquor: One drink = 1.5 ounces of liquor; Wine: One drink = 5 
ounces) 
  □	 0 Drinks 
	  □	 1-2 Drinks 
  □	 3 or more Drinks 
	
11. Please check any of the following medications (prescription and/or over the counter) you 
currently take regularly. Also give the name of the medication. 
	 	 	 Medication   Name of Medication 
  □ Heart Medicine  __________________ 
  □ Blood Pressure Medicine __________________ 
  □ Blood cholesterol Medicine __________________ 
  □ Hormones   __________________ 
  □ Birth Control pills  __________________ 
  □ Medicine for breathing/lungs __________________ 
  □ Insulin    __________________ 
  □ Other medicine for diabetes __________________ 
  □ Arthritis Medicine  __________________ 
  □ Medicine for depression __________________ 
  □ Medicine for anxiety  __________________ 
  □ Thyroid Medicine  __________________ 
  □ Medicine for Ulcers  __________________ 
  □ Pain killer Medicine  __________________ 
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  □ Allergy Medicine  __________________ 
  □ HIV/AIDS Medicine  __________________ 
  □ Hepatitis Medicine  __________________ 
  □ Other (please specifiy)  __________________ 
Supplement Use 
12. Are you presently using or have you used within the last 12 months the following supplements at 
least three times/week: 
Type of Dietary 
Supplement 
 
Note:  If calcium and vitamin 
D are taken as one 
supplement, separate into 
two categories under "single 
vitamin" and "single mineral". 
If a supplement contains 
more than 3 components, 
enter as either "multivitamin", 
"multimineral", or 
"multivitamin/mineral". 
Provide Brand Name 
or Type (i.e., vitamin E, 
calcium, iron, etc.) 
Add important 
comments 
Use Dosage/Tab 
(single 
substances) 
& Units 
Cups for 
herbal teas 
Spoons or 
scoops for 
some 
No. 
Tabs 
per time 
point 
No. 
Times: 
Per day 
or 
Per week 
Last Used 
(mm/yyyy) 
Multivitamin     NA 
      
Multimineral     NA 
      
Multivitamin/mineral     NA 
      
Single vitamin(s)      
      
      
      
      
Single mineral(s)      
      
      
      
      
Herbal dietary 
supplement(s) 
     
      
      
      
Herbal tea*  NA    
      
      
Other over-the-counter 
supplement(s) 
     
      
      
      
Fiber Supplement (i.e., 
Metamucil, Fibercon) 
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Physical Fitness, Physical Activity/Exercise 
13.   In general, compared to other persons your age, rate how physically fit you are: 
 1 □		2	□		3	□		4	□		5	□		6	□		7	□		8	□		9	□		10	□	
	 Not at all      Somewhat               Extremely 
 Physically active     physically active              physically fit	 	
14. Outside of your normal work or daily responsibilities, how often do you engage in exercise that at 
least moderately  
increases your breathing and heart rate, and makes you sweat, for at least 20 minutes (such as 
brisk walking, cycling, swimming, jogging, aerobic dance, stair climbing, rowing, basketball, 
racquetball, vigorous yard work, etc.) 
	 □	 5 or more times per week	 □	3 to 4 times per week	□	1 to 2 times per week 
	 □	Less than 1 time per week		 □	Seldom or never 
15. How much hard physical work is required on your job? 
 □	 A great deal	 □	A moderate amount   □	None 
16. How long have you exercised or played sports regularly? 
 □	 I do not exercise regularly	 □	less than 1 year	□	1 to 2 years 
	 □	2-5 years		 □	5-10 years    □	more than 10 years 
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APPENDIX	D	
Supplement	Instructions	
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Packet	Instructions:	
	
• Consume	packets	each	evening	with	dinner.		
• Mix	contents	of	two	packets	with	one	cup	(8-oz)	of	water.	Once	consumed,	use	
additional	water	to	consume	any	residual	powder.	
• Avoid	consuming	supplement	with	dairy	products	(milk	&	yogurt).	
• Return	packets	to	their	respective	weekly	zip-lock	bags	and	bring	bags	back	to	
lab	at	6-week	follow-up	visit.	
	
Please	answer	the	following	questions	and	return	this	sheet	at	6-week	follow-up:	
	
1. Which	supplement	do	you	think	you	were	consuming?	(Placebo	or	Blueberry)	
	
Did	you	notice	any	side-effects	during	the	6-week	supplementation	period?	
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APPENDIX	E	
Participant	Contact	Information	
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Contact	Information:	
	
	
Participant	Number:	______	
	
Phone:	______________________	 E-mail:	______________________	
	
Preferred	method	of	contact?	(circle	one)	 PHONE	 /E-MAIL	
	
	
Anthropometric	Information:	
	
Baseline	Ht:	________	
	 	
Baseline	Wt:	_______	Visit	Two	Wt:	_______	Visit	Three	Wt:	_______	
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APPENDIX	F	
Three-Day	Diet	Record	–	Food	Recording	Form	
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Food Recording Form 
	
	
Subject	number______				 	 	 	 	 Date	__________	
	 	 	 	 	 	 	 	 	 	 (mm/dd/yyyy)	
	
	
Directions for Using the Food Diary 
1. Please	record	ALL	food,	beverage,	and	supplements	eaten/ingested	for	the	three	
days	that	are	assigned	for	you.		To	reduce	error,	please	follow	these	directions:	
	
a. Keep	your	food	diary	current	(list	foods	immediately	after	they	are	
eaten).	
	
b. Whenever	possible,	MEASURE	the	volume	consumed	by	using	cups	and	
tablespoons.		Record	amounts	in	household	measures---ounces,	
tablespoons,	cups,	and	slices.	
	
c. Be	specific	when	describing	the	foot	item	eaten,	and	the	method	that	was	
used	to	prepare	the	food.		Remember	to	include	condiments,	sugar,	oils,	
butter,	and	other	visible	fats		For	example:	
	 Apple,	raw,	fresh,	with	peel				 	 1	medium	
	 Bread,	whole	wheat,	fresh					 	 2	slices	
	 Margarine,	soft	from	tub	 	 	 1	tablespoon	
	 Cereal,	corn	flakes	 	 	 1.5	cups	
	 Sugar,	white	 	 	 	 1	teaspoon	
	 Milk,	non	fat	 	 	 	 2	cups	
	 Fish,	salmon,	baked	 	 	 10	ounces	
	
d.	 This	food	record	will	be	analyzed	with	a	computerized	dietary	analysis	
program,	so	please	provide	sufficient	detail.	
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Week	One	Day	One	
Time	
Food/Beverage	
Consumed	
Food	Item	and	Method	of	
Preparation	
Amount	
Eaten	(in	cups,	
tablespoons,	
ounces,	etc.)	
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Week	One	Day	Two	
Time	
Food/Beverage	
Consumed	
Food	Item	and	Method	of	
Preparation	
Amount	
Eaten	(in	cups,	
tablespoons,	
ounces,	etc.)	
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Week	One	Day	Three	
Time	
Food/Beverage	
Consumed	
Food	Item	and	Method	of	
Preparation	
Amount	
Eaten	(in	cups,	
tablespoons,	
ounces,	etc.)	
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Week	Six	Day	One	
Time	
Food/Beverage	
Consumed	
Food	Item	and	Method	of	
Preparation	
Amount	
Eaten	(in	cups,	
tablespoons,	
ounces,	etc.)	
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Week	Six	Day	Two	
Time	
Food/Beverage	
Consumed	
Food	Item	and	Method	of	
Preparation	
Amount	
Eaten	(in	cups,	
tablespoons,	
ounces,	etc.)	
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Week	Six	Day	Three	
Time	
Food/Beverage	
Consumed	
Food	Item	and	Method	of	
Preparation	
Amount	
Eaten	(in	cups,	
tablespoons,	
ounces,	etc.)	
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APPENDIX	G	
Portion	Size	Diagram	
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APPENDIX	H	
Biopsy	Care	Instructions	
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Instructions	for	Care	of	the	Muscle	Biopsy	Area	
	
	 Here	are	some	instructions	for	you	to	take	care	of	the	muscle	biopsy	area	so	that	it	heals	well	and	
the	chance	of	infection	is	minimized.	We’ve	also	included	what	is	normal	and	what	is	not	normal	as	part	
of	the	healing	process.	
	
General	Instructions	
	
• Keep the pressure wrap on for at least 8 hours following the biopsy. 
• Keep the steri-strip(s) and Band-Aids on for as long as possible (until they fall off ~4 days). 
• Trim the loose ends of the steri-strip as needed. 
• Replace steri-strip(s) if it completely comes off before 4 days.  
• It is OK to shower, but you will want to avoid taking a bath or using a hot tub or swimming pool 
for at least 4 days. Change Band-Aids after showering to keep the incision dry. 
• If you have had stitches, arrange to have them removed about 5-7 days after the biopsy.  
• Icing the biopsy area is suggested for immediately after and the days following. 
• You are encouraged to walk and renew normal activity within 1-2 days. There is no need to ‘baby 
it’. 
 
Do	Not:	
• Perform intense, “all-out” exercise for 1-2 days. 
• Get in a river, lake, pool, or hot tub for at least 4 days after the biopsy. 
• Consume any pain-relief medications without checking with us first. 
 
Normal	Reactions	following	Muscle	Biopsy:	
• Localized stiffness, soreness, and bruising (light to moderate). 
• There may be soreness and slight weakness in the biopsied leg that is noticeable when you go 
down stairs. You will want to go slowly, lead with the opposite leg, and use the handrail the day of 
the biopsy. 
 
Reactions	Not	Normal	Following	Muscle	Biopsy:	
• Intense, excruciating pain in the leg or in the area of the biopsy 
• Bleeding which does not stop 
• Intense redness in the area of the biopsy 
• Heat in the area of the biopsy 
• Presence of pus 
• Fever 
• Hives or other signs consistent with allergic reaction (i.e. difficulty breathing, swelling) 
   
  IF YOU EXPERIENCE ANY OF THE ABNORMAL REACTIONS ABOVE, CONTACT US 
IMMEDIATELY - REGARDLESS OF THE TIME OF DAY.  IN CASE OF AN EMERGENCY, DO 
NOT HESITATE TO GO TO THE EMERGENCY ROOM OR CALL 911. 
Kevin Zwetsloot, Ph.D. wk 828-262-7281 cell 828-406-3862 
Ed Merritt, Ph.D. wk 828-262-7986 cell 512-779-8039 
Cate Trate, M.D. wk 828-264-7760 cell 828-268-1755	
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APPENDIX	I	
FRAP	Protocol	
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FERRIC	REDUCING	ABILITY	OF	PLASMA	(FRAP)	
Modified	for	96	Well	Plate	
	
1.	Collect	and	snap	freeze	plasma.		Store	at	-80	until	analysis.	
	
Assay	procedures:		Note:	Remove	and	discard	top	layer	of	all	solid	chemicals	before	using	
	
1.	Make	up	300	mmol/L	acetate	buffer	(adjust	to	pH	3.6)	Light	Sensitive	
	 a.	weigh	3.1	grams	sodium	acetate	trihydrate	(On	dry	chem.	Shelf)	
	 b.	add	16	ml	acetic	acid	(1N)	(Molarity	=	Normality/Valence)	(In	Corrosives	cabinet)	
	 c.	bring	to	final	volume	of	one	liter	with	DI	water	
	
2.	Make	up	10	mmol/L	TPTZ	(2,4,6	-	tripyridyl-s-triazine)	(store	in	refrigerator)	(MW=312.3)	in	40	mmol	HCl	(In	
Corrosives	cabinet)	(adjust	to	make	30	mL)	
	
a. make	up	40	mmol/l	HCl	(Molarity	=	Normality/Valence)	Examples:	(330	uL	HCl	(12N)	+	99.670	mL	DDI	
water	(in	hood)		
	
b. weigh	out	187.38	mg	TPTZ	(In	Fridge)	
	
c.	add	TPTZ	to	60	mL		HCl,	final	concentration	=	10	mmol	and	mix	until	dissolved.	
	
3.	Make	up	20	mmol/L	iron	trichloride	hexhydrate	(ITX)	(MW=270.29)	in	DDI	water	(Make	100	mL)	
(0.54g	ITX	+	100	mL	DI)	(ITX	stored	on	Dry	Chem	Shelf)	
	
4.	Make	up	working	FRAP	solution	(300	mL	total	volume)	(Note:	solution	should	be	bright	orange	color,	if	color	is	
dark	purple	or	purple	tinted,	your	iron	hexhydrate	was	most	likely	pre-oxidized.)	 	
	
	 a.	measure	out	200	ml	acetate	buffer	
	 b.	add	20	ml	TPTZ	solution	
	 c.	add	20	ml	ITX	solution	
This	is	good	to	run	multiple	plates	with	multiple	samples	on	it.		Also	note,	it	is	a	1:1:1:	ratio	so	you	can	use	
100mL:10mL:10mL	respectively)	
	
5.	STD	Curve.		Make	up	100,	200,	400,	600,	800,	and	1000	uM/L	solutions	of	ascorbate/trolox	in	DI	water.	
For	ascorbate,	measure	44	mg	ascorbate	+	250	mL	DI	to	make	1000	uM	ascorbate.			
	
Concentration	(ascorbate)	 Amount	 DI	H2O	
1000	uM	 5.0	mL	 0	mL	
800	uM	 4.0	mL	 1	mL	
600	uM	 3.0	mL	 2	mL	
400	uM	 2.0	mL	 3	mL	
200	uM	 1.0	mL	 4	mL	
100	uM	 0.5	mL	 4.5	mL	
0	uM	 0.0	mL	 5	mL	
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APPENDIX	J	
F2-Isoprostane	Protocol	
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8-Isoprostane	Express	ELISA	Kit	
Cayman’s	8-Isoprostane	Express	ELISA	Kit	is	a	competitive	assay	that	can	be	used	for	
quantification	of	8-isoprostane	in	plasma,	urine,	and	other	sample	matrices.	The	assay	has	a	
range	from	2.5-1,500	pg/ml	and	a	sensitivity	(80%	B/B0)	of	approximately	10	pg/ml.		
8-Isoprostane	Express	ELISA	Standard		
• Equilibrate	a	pipette	tip	in	ethanol	by	repeatedly	filling	and	expelling	the	tip	with	
ethanol	several	times.	Using	the	equilibrated	pipette	tip,	transfer	100	μl	of	the	8-
Isoprostane	Express	ELISA	Standard	(Item	No.	416364)	into	a	clean	test	tube,	then	
dilute	with	900	μl	UltraPure	water.	The	concentration	of	this	solution	(the	bulk	
standard)	will	be	15	ng/ml.		
NOTE:	If	assaying	culture	medium	samples	that	have	not	been	diluted	with	ELISA	Buffer,	culture	
medium	should	be	used	in	place	of	ELISA	Buffer	for	dilution	of	the	standard	curve.		
• To	prepare	the	standard	for	use	in	ELISA:	obtain	eight	clean	test	tubes	and	number	
them	#1	through	#8.	Aliquot	900	μl	ELISA	Buffer	to	tube	#1	and	600	μl	ELISA	Buffer	to	
tubes	#2-8.	Transfer	100	μl	of	the	bulk	standard	(15	ng/ml)	to	tube	#1	and	mix	
thoroughly.	The	concentration	of	this	standard,	the	rst	point	on	the	standard	curve,	will	
be	1,500	pg/ml.	Serially	dilute	the	standard	by	removing	400	μl	from	tube	#1	and	
placing	in	tube	#2;	mix	thoroughly.	Next,	remove	400	μl	from	tube	#2	and	place	it	into	
tube	#3;	mix	thoroughly.	Repeat	this	process	for	tubes	#4-8.	These	diluted	standards	
should	not	be	stored	for	more	than	24	hours.		
	
	
8-Isoprostane	Express	AChE	Tracer		
• Reconstitute	the	8-Isoprostane	Express	AChE	Tracer	as	follows:		
o 100	dtn	8-Isoprostane	Express	AChE	Tracer	(96-well	kit;	Item	No.	
416360):	Reconstitute	with	6	ml	ELISA	Buffer.		
OR 500	dtn	8-Isoprostane	Express	AChE	Tracer	(480-well	kit;	Item	No.		
416360):	Reconstitute	with	30	ml	ELISA	Buffer.		
Store	the	reconstituted	8-Isoprostane	Express	AChE	Tracer	at	4°C	(do	not	
freeze!)	and	use	within	four	weeks.	A	20%	surplus	of	tracer	has	been	included	to	
account	for	any	incidental	losses.	
8-Isoprostane	Express	ELISA	Antiserum		
	
	
	66 
• Reconstitute	the	8-Isoprostane	Express	ELISA	Antiserum	as	follows:		
o 100	dtn	8-Isoprostane	Express	ELISA	Antiserum	(96-well	kit;	Item	No.	
416362):	Reconstitute	with	6	ml	ELISA	Buffer.		
OR 500	dtn	8-Isoprostane	Express	ELISA	Antiserum	(480-well	kit;	Item	
No.	416362):	Reconstitute	with	30	ml	ELISA	Buffer.		
Store	the	reconstituted	8-Isoprostane	Express	ELISA	Antiserum	at	4°C.	It	will	be	
stable	for	at	least	four	weeks.	A	20%	surplus	of	antiserum	has	been	included	to	
account	for	any	incidental	losses.		
Plate	Set	Up		
The	96-well	plate(s)	included	with	this	kit	is	supplied	ready	to	use.	It	is	not	necessary	to	rinse	
the	plate(s)	prior	to	adding	the	reagents.	NOTE:	If	you	do	not	need	to	use	all	the	strips	at	once,	
place	the	unused	strips	back	in	the	plate	packet	and	store	at	4°C.	Be	sure	the	packet	is	sealed	with	
the	desiccant	inside.		
Each	plate	or	set	of	strips	must	contain	a	minimum	of	two	blanks	(Blk),	two	non-	specific	
binding	wells	(NSB),	two	maximum	binding	wells	(B0),	and	an	eight	point	standard	curve	run	in	
duplicate.	NOTE:	Each	assay	must	contain	this	minimum	configuration	in	order	to	ensure	accurate	
and	reproducible	results.	Each	sample	should	be	assayed	at	two	dilutions	and	each	dilution	
should	be	assayed	in	duplicate.	For	statistical	purposes,	we	recommend	assaying	samples	in	
triplicate.		
A	suggested	plate	format	is	shown	in	Figure	5,	below.	The	user	may	vary	the	location	and	type	
of	wells	present	as	necessary	for	each	particular	experiment.	The	plate	format	provided	below	
has	been	designed	to	allow	for	easy	data	analysis	using	a	convenient	spreadsheet	offered	by	
Cayman.	
	
Performing	the	Assay	
Addition	of	the	Reagents:		
1. ELISA	Buffer	 	
Add	100	μl	ELISA	Buffer	to	NSB	wells.	Add	50	μl	ELISA	Buffer	to	B0	wells.	If	culture	
medium	was	used	to	dilute	the	standard	curve,	substitute	50	μl	of	culture	medium	for	
ELISA	Buffer	in	the	NSB	and	B0	wells	(i.e.,	add	50	μl	culture	medium	to	NSB	and	B0	
wells	and	50	μl	ELISA	Buffer	to	NSB	wells).	 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2. 8-Isoprostane	Express	ELISA	Standard	 	
Add	50	μl	from	tube	#8	to	both	of	the	lowest	standard	wells	(S8).	Add	50	μl	from	tube	
#7	to	each	of	the	next	two	standard	wells	(S7).	Continue	with	this	procedure	until	all	the	
standards	are	aliquoted.	The	same	pipette	tip	should	be	used	to	aliquot	all	the	
standards.	Before	pipetting	each	standard,	be	sure	to	equilibrate	the	pipette	tip	in	that	
standard.	 	
3. Samples	 	
Add	50	μl	of	sample	per	well.	Each	sample	should	be	assayed	at	a	minimum	of	two	
dilutions.	Each	dilution	should	be	assayed	in	duplicate	(triplicate	recommended).	 	
4. 8-Isoprostane	Express	AChE	Tracer	 	
Add	50	μl	to	each	well	except	the	TA	and	the	Blk	wells.	 	
5. 8-Isoprostane	Express	ELISA	Antiserum	
Add	50	μl	to	each	well	except	the	TA,	the	NSB,	and	the	Blk	wells.		
Incubation	of	the	Plate		
Cover	each	plate	with	plastic	film	and	incubate	for	two	hours	at	room	temperature	on	an	orbital	
shaker.		
Development	of	the	Plate		
1. Reconstitute	Ellman’s	Reagent	immediately	before	use	(20	ml	of	reagent	is	sufficient	to	
develop	100	wells):		
	
o 100	dtn	vial	Ellman’s	Reagent:	Reconstitute	with	20	ml	of	UltraPure	water.		
OR 	
o 250	dtn	vial	Ellman’s	Reagent:	Reconstitute	with	50	ml	of	UltraPure	water.		
	
2. Empty	the	wells	and	rinse	five	times	with	Wash	Buffer.	 	
	
3. Add	200	μl	of	Ellman’s	Reagent	to	each	well.		
	
4. Add	5	μl	of	tracer	to	the	TA	wells.	 	
	
5. Cover	the	plate	with	plastic	film.	Optimum	development	is	obtained	by	using	an	orbital	
shaker	equipped	with	a	large,	flat	cover	to	allow	the	plate(s)	to	develop	in	the	dark	at	
room	temperature.	This	assay	typically	develops	(i.e.,	B0	wells	≥0.3	A.U.	(blank	
subtracted))	in	60-90	minutes.	 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Reading	the	Plate		
1. Wipe	the	bottom	of	the	plate	with	a	clean	tissue	to	remove	fingerprints,	dirt,	etc.	 	
	
2. Remove	the	plate	cover	being	careful	to	keep	Ellman’s	Reagent	from	splashing	on	the	
cover.	NOTE:	Any	loss	of	Ellman’s	Reagent	will	affect	the	absorbance	readings.	If	Ellman’s	
Reagent	is	present	on	the	cover,	use	a	pipette	to	transfer	the	Ellman’s	Reagent	into	the	
well.	If	too	much	Ellman’s	Reagent	has	splashed	on	the	cover	to	easily	redistribute	back	
into	the	wells,	wash	the	plate	three	times	with	wash	buffer	and	repeat	the	development	
with	fresh	Ellman’s	Reagent.	 	
	
3. Read	the	plate	at	a	wavelength	between	405-420	nm.	The	absorbance	may	be	checked	
periodically	until	the	B0	wells	have	reached	a	minimum	of	0.3	A.U.	(blank	subtracted).	
The	plate	should	be	read	when	the	absorbance	of	the	B0	wells	is	in	the	range	of	0.3-1.0	
A.U.	(blank	subtracted).	If	the	absorbance	of	the	wells	exceeds	2.0,	wash	the	plate,	add	
fresh	Ellman’s	Reagent	and	let	it	develop	again.	
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APPENDIX	–	K	
Collected	Data	
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Participant	1-11	Descriptive	and	Compliance	Data	
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Participant	12-23	Descriptive	and	Compliance	Data	
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Participant	1-11	Diet	Data	
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Participant	12-23	Diet	Data	
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FRAP	–	Raw	Data	
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F2-Isoprostane	–	Raw	Data	
	
Plate	1	
Participant	
#/Visit		 		 pg/mL	 		 StdDev	 %CV	
		 3A	 		 88.650	 		 		 		
		 3B	 		 67.445	 		 		 		
		 3C	 		 99.635	 		 		 		
		 5A	 		 50.015	 		 		 		
		 5B	 		 44.855	 		 		 		
		 5C	 		 27.525	 		 		 		
		 6A	 		 132.260	 		 		 		
		 6B	 		 177.345	 		 		 		
		 6C	 		 197.394	 		 		 		
		 7A	 		 74.447	 		 		 		
		 7B	 		 151.483	 		 		 		
		 7D	 		 73.007	 		 		 		
		 8A	 		 68.533	 		 		 		
		 8B	 		 62.593	 		 		 		
		 8C	 		 111.443	 		 		 		
		 9A	 		 228.220	 		 		 		
		 9B	 		 74.447	 		 		 		
		 9C	 		 132.770	 		 		 		
		 10A	 		 173.043	 		 		 		
		 10B	 		 115.443	 		 		 		
		 CBStD	 		 120.437	 		 		 		
		 		 		 		 		 		 		
Plate	2	 		 		 pg/mL	 		 StdDev	 %CV	
		 10C	 		 95.480	 		 31.051	 32.521	
		 11A	 		 55.825	 		 11.758	 21.063	
		 11B	 		 74.502	 		 19.291	 25.893	
		 11C	 		 149.047	 		 37.312	 25.033	
		 12A	 		 66.195	 		 6.808	 10.284	
		 12B	 		 59.841	 		 9.731	 16.262	
		 12C	 		 61.839	 		 9.280	 15.007	
		 13A	 		 57.204	 		 2.417	 4.225	
		 13B	 		 64.734	 		 17.895	 27.644	
		 13C	 		 51.347	 		 4.192	 8.165	
		 15A	 		 91.432	 		 7.205	 7.880	
		 15B	 		 176.070	 		 52.583	 29.865	
		 15C	 		 227.967	 		 281.869	 123.645	
		 16A	 		 103.023	 		 19.504	 18.931	
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		 16B	 		 66.015	 		 17.866	 27.064	
		 16C	 		 128.369	 		 43.843	 34.153	
		 17A	 		 63.042	 		 2.865	 4.544	
		 17B	 		 97.963	 		 48.812	 49.826	
		 17C	 		 86.654	 		 23.783	 27.446	
		 18A	 		 148.341	 		 45.702	 30.809	
		 CBStD	 		 60.373	 		 8.108	 13.429	
		 		 		 		 		 		 		
Plate	3	 		 		 pg/mL	 		 StdDev	 %CV	
		 18B	 		 95.640	 		 8.838	 9.241	
		 18C	 		 68.584	 		 26.009	 37.923	
		 19A	 		 77.016	 		 31.550	 40.965	
		 19B	 		 109.868	 		 28.879	 26.285	
		 19C	 		 139.723	 		 46.503	 33.282	
		 20A	 		 96.018	 		 17.523	 18.250	
		 20B	 		 110.388	 		 20.301	 18.391	
		 20C	 		 130.983	 		 50.124	 38.267	
		 21A	 		 74.415	 		 23.071	 31.003	
		 21B	 		 108.584	 		 33.517	 30.867	
		 21C	 		 74.631	 		 15.592	 20.893	
		 22A	 		 114.521	 		 18.429	 16.092	
		 22B	 		 142.217	 		 26.201	 18.423	
		 22C	 		 101.748	 		 13.272	 13.044	
		 23A	 		 91.208	 		 10.305	 11.298	
		 23B	 		 141.046	 		 15.290	 10.841	
		 23C	 		 130.128	 		 31.211	 23.985	
		 CBStD	 		 98.433	 		 2.342	 2.379	
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continue		his	academic	career	as	he	begins	doctoral	studies	at	the	
University	of	Alabama	at	Birmingham.	
	
